Neutralization of GDF15 Prevents Anorexia and Weight Loss in the Monocrotaline-Induced Cardiac Cachexia Rat Model
Open Access
Abstract
Growth and differentiation factor 15 (GDF15) is a cytokine reported to cause anorexia and weight loss in animal models. Neutralization of GDF15 was efficacious in mitigating cachexia and improving survival in cachectic tumor models. Interestingly, elevated circulating GDF15 was reported in patients with pulmonary arterial hypertension and heart failure, but it is unclear whether GDF15 contributes to cachexia in these disease conditions. In this study, rats treated with monocrotaline (MCT) manifested a progressive decrease in body weight, food intake, and lean and fat mass concomitant with elevated circulating GDF15, as well as development of right-ventricular dysfunction. Cotreatment of GDF15 antibody mAb2 with MCT prevented MCT-induced anorexia and weight loss, as well as preserved lean and fat mass. These results indicate that elevated GDF15 by MCT is causal to anorexia and weight loss. GDF15 mAb2 is efficacious in mitigating MCT-induced cachexia in vivo. Furthermore, the results suggest GDF15 inhibition is a potential therapeutic approach to alleviate cardiac cachexia in patients.Keywords
This publication has 46 references indexed in Scilit:
- TGF-b Superfamily Cytokine MIC-1/GDF15 Is a Physiological Appetite and Body Weight RegulatorPLOS ONE, 2013
- The monocrotaline model of pulmonary hypertension in perspectiveAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- Serial Measurement of Growth-Differentiation Factor-15 in Heart FailureCirculation, 2010
- Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexiaJournal of Applied Physiology, 2008
- Cachexia: A new definitionClinical Nutrition, 2008
- Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart FailureJACC, 2007
- Cardiac cachexiaAnnals of Medicine, 2004
- Apoptosis in the Skeletal Muscle of Rats with Heart Failure is Associated with Increased Serum Levels of TNF-α and SphingosineJournal of Molecular and Cellular Cardiology, 2001
- Skeletal Muscle Function and Its Relation to Exercise Tolerance in Chronic Heart FailureJACC, 1997
- Wasting as independent risk factor for mortality in chronic heart failureThe Lancet, 1997